Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
Covid19-Sources
(7) Michael Lin, PhD-MD auf Twitter: "Antibodies elicited by the Pfizer/BioNTech RNA vax are 6x less potent in neutralizing B.1.617 (delta variant that devastated India). This lowers predicted efficacy for symptomatic COVID19 to ~70%. This compares to 2x drop in neutralizing activity for Covaxin. I discuss in 🧵" / Twitter
Corona-Pandemie: Kursiert das Virus schon seit Herbst? - Wissen - SZ.de
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Long COVID in children: Partnerships between families and paediatricians are a priority for better care - Buonsenso - - Journal of Paediatrics and Child Health - Wiley Online Library
Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity
Rüdiger Groß auf Twitter: "Our preprint on heterologous COVID-19 vaccination is out! We report reactogenicity & immunogenicity (antibodies, T cells) after AZ prime and BNT/Pfizer boost with an 8w interval; compare antibody levels to a cohort with 2x BNT vaccination. (1/8) 🧵 https://t.co/hKwGANbiyg" / Twitter
InI4🌍 Spread Ideas Not Viruses, hat einen Schuss auf Twitter: "Wichtiger als Kinder durchimpfen wäre mir doch wieder #NoCovid/#LowCovid. Zumal wir auch Mitmenschen allen Alters haben, die man nicht oder nicht wirksam impfen kann." / Twitter
Extended interval BNT162b2 vaccination enhances peak antibody generation in older people
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Process-related impurities in the ChAdOx1 nCov-19 vaccine
Long COVID affects home-isolated young patients
Host Proteins Identified in Extracellular Viral Particles as Targets for Broad-Spectrum Antiviral Inhibitors
Marc Bevand auf Twitter: "#7 "Masks don't work" 70 papers and reviews disagree: https://t.co/YObJUa8EAD" / Twitter
The indirect effect of mRNA-based Covid-19 vaccination on unvaccinated household members
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents | NEJM
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
The MicrobeScope – Infectious Diseases in Context — Information is Beautiful
Mix-and-match COVID vaccines trigger potent immune response
How Did We Get Here: What Are Droplets and Aerosols and How Far Do They Go? A Historical Perspective on the Transmission of Respiratory Infectious Diseases by Katherine Randall, E. Thomas Ewing, Linsey Marr, Jose Jimenez, L. Bourouiba :: SSRN
Estimating infectiousness throughout SARS-CoV-2 infection course
The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial | Infectious Diseases | JAMA | JAMA Network
Safety of mRNA COVID-19 jabs backed, despite myocarditis cases -
“Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines